Efficacy and Safety of LY2963016 Insulin Glargine Compared with Insulin Glargine (Lantus®) in Patients with Type 1 Diabetes in a Randomised Controlled Trial (The ELEMENT 1 Study)

ConclusionsBoth LY IGlar and IGlar, when used in combination with mealtime insulin lispro, provided effective and similar glucose control and similar safety profiles.

Source: Diabetes, Obesity and Metabolism - May 15, 2015 Category: Endocrinology Authors: T.C. Blevins, D. Dahl, J. Rosenstock, L.L. Ilag, W.J. Huster, J.S. Zielonka, R.K. Pollom, M.J. Prince Tags: ORIGINAL ARTICLE Source Type: research